Natdac 60 Daclatasvir Dihydrochloride 60 Mg
Product Details:
- Indication Treatment of Chronic Hepatitis C Virus (HCV) infection
- Assay Not less than 98.0% and not more than 102.0%
- Origin of Medicine India
- Expiration Date 2 years from the date of manufacture
- CAS No 1009119-65-6
- Appearance Yellow biconvex film-coated tablet
- Molecular Formula C40H52N8O6
- Click to view more
X
Natdac 60 Daclatasvir Dihydrochloride 60 Mg Product Specifications
- Yellow biconvex film-coated tablet
- 1009119-65-6
- 2 years from the date of manufacture
- India
- Treatment of Chronic Hepatitis C Virus (HCV) infection
- Not less than 98.0% and not more than 102.0%
- Oral administration as prescribed by a healthcare provider
- Store below 30°C in a dry place protected from light
- 28 tablets per box
- C40H52N8O6
- Pharmaceutical Grade
- Allopathic
- Daclatasvir Dihydrochloride
- Tablet
- 60 mg per tablet
Other Products in 'Anti Infective Medicine' category
Get in touch with us


